Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Direct measurement of kinetic parameters of ABCG2-dependent transport of natural flavonoids using a fluorogenic substrate.

Rozanski M, Studzian M, Pulaski L.

J Pharmacol Exp Ther. 2019 Sep 9. pii: jpet.119.261347. doi: 10.1124/jpet.119.261347. [Epub ahead of print]

2.

Effect of filtration on elimination of turbidity and changes in volatile compounds concentrations in plum distillates.

Balcerek M, Pielech-Przybylska K, Dziekońska-Kubczak U, Patelski P, Różański M.

J Food Sci Technol. 2019 Apr;56(4):2049-2062. doi: 10.1007/s13197-019-03682-0. Epub 2019 Mar 6.

3.

Telemedicine in Prehospital Acute Stroke Care.

Geisler F, Kunz A, Winter B, Rozanski M, Waldschmidt C, Weber JE, Wendt M, Zieschang K, Ebinger M, Audebert HJ; Stroke Emergency Mobile (STEMO) Consortium.

J Am Heart Assoc. 2019 Mar 19;8(6):e011729. doi: 10.1161/JAHA.118.011729.

4.

4G versus 3G-enabled telemedicine in prehospital acute stroke care.

Winter B, Wendt M, Waldschmidt C, Rozanski M, Kunz A, Geisler F, Grittner U, Kaczmarek S, Ebinger M, Audebert HJ; Stroke Emergency Mobile (STEMO) Consortium.

Int J Stroke. 2019 Aug;14(6):620-629. doi: 10.1177/1747493019830303. Epub 2019 Mar 15.

PMID:
30875277
5.

Evaluation of a score for the prehospital distinction between cerebrovascular disease and stroke mimic patients.

Geisler F, Ali SF, Ebinger M, Kunz A, Rozanski M, Waldschmidt C, Weber JE, Wendt M, Winter B, Schwamm LH, Audebert HJ.

Int J Stroke. 2019 Jun;14(4):400-408. doi: 10.1177/1747493018806194. Epub 2018 Oct 10.

PMID:
30303808
6.

Ultraearly Intravenous Thrombolysis for Acute Ischemic Stroke in Mobile Stroke Unit and Hospital Settings.

Tsivgoulis G, Geisler F, Katsanos AH, Kõrv J, Kunz A, Mikulik R, Rozanski M, Wendt M, Audebert HJ.

Stroke. 2018 Aug;49(8):1996-1999. doi: 10.1161/STROKEAHA.118.021536.

PMID:
29986934
7.

Effects of Prehospital Thrombolysis in Stroke Patients With Prestroke Dependency.

Nolte CH, Ebinger M, Scheitz JF, Kunz A, Erdur H, Geisler F, Braemswig TB, Rozanski M, Weber JE, Wendt M, Zieschang K, Fiebach JB, Villringer K, Grittner U, Kaczmarek S, Endres M, Audebert HJ.

Stroke. 2018 Mar;49(3):646-651. doi: 10.1161/STROKEAHA.117.019060. Epub 2018 Feb 19. Erratum in: Stroke. 2018 Apr;49(4):e173.

PMID:
29459395
8.

Exogenous growth factors bFGF, EGF and HGF do not influence viability and phenotype of V600EBRAF melanoma cells and their response to vemurafenib and trametinib in vitro.

Zalesna I, Osrodek M, Hartman ML, Rozanski M, Sztiller-Sikorska M, Niewinna K, Nejc D, Czyz M.

PLoS One. 2017 Aug 22;12(8):e0183498. doi: 10.1371/journal.pone.0183498. eCollection 2017.

9.

Effects of Ultraearly Intravenous Thrombolysis on Outcomes in Ischemic Stroke: The STEMO (Stroke Emergency Mobile) Group.

Kunz A, Nolte CH, Erdur H, Fiebach JB, Geisler F, Rozanski M, Scheitz JF, Villringer K, Waldschmidt C, Weber JE, Wendt M, Winter B, Zieschang K, Grittner U, Kaczmarek S, Endres M, Ebinger M, Audebert HJ.

Circulation. 2017 May 2;135(18):1765-1767. doi: 10.1161/CIRCULATIONAHA.117.027693. No abstract available.

PMID:
28461420
10.

Vemurafenib and trametinib reduce expression of CTGF and IL-8 in V600EBRAF melanoma cells.

Hartman ML, Rozanski M, Osrodek M, Zalesna I, Czyz M.

Lab Invest. 2017 Feb;97(2):217-227. doi: 10.1038/labinvest.2016.140. Epub 2017 Jan 9.

11.

Glial Fibrillary Acidic Protein for Prehospital Diagnosis of Intracerebral Hemorrhage.

Rozanski M, Waldschmidt C, Kunz A, Grittner U, Ebinger M, Wendt M, Winter B, Bollweg K, Villringer K, Fiebach JB, Audebert HJ.

Cerebrovasc Dis. 2017;43(1-2):76-81. doi: 10.1159/000453460. Epub 2016 Dec 13.

PMID:
27951536
12.

S-Geranyl-2-thiouridine wobble nucleosides of bacterial tRNAs; chemical and enzymatic synthesis of S-geranylated-RNAs and their physicochemical characterization.

Sierant M, Leszczynska G, Sadowska K, Dziergowska A, Rozanski M, Sochacka E, Nawrot B.

Nucleic Acids Res. 2016 Dec 15;44(22):10986-10998. Epub 2016 Aug 26.

13.

Functional outcomes of pre-hospital thrombolysis in a mobile stroke treatment unit compared with conventional care: an observational registry study.

Kunz A, Ebinger M, Geisler F, Rozanski M, Waldschmidt C, Weber JE, Wendt M, Winter B, Zieschang K, Fiebach JB, Villringer K, Erdur H, Scheitz JF, Tütüncü S, Bollweg K, Grittner U, Kaczmarek S, Endres M, Nolte CH, Audebert HJ.

Lancet Neurol. 2016 Sep;15(10):1035-43. doi: 10.1016/S1474-4422(16)30129-6. Epub 2016 Jul 16.

PMID:
27430529
14.

Influence of Distance to Scene on Time to Thrombolysis in a Specialized Stroke Ambulance.

Koch PM, Kunz A, Ebinger M, Geisler F, Rozanski M, Waldschmidt C, Weber JE, Wendt M, Winter B, Zieschang K, Bollweg K, Kaczmarek S, Endres M, Audebert HJ.

Stroke. 2016 Aug;47(8):2136-40. doi: 10.1161/STROKEAHA.116.013057. Epub 2016 Jun 21.

PMID:
27328702
15.
16.

Adverse events of postoperative thoracic epidural analgesia: A retrospective analysis of 7273 cases in a tertiary care teaching hospital.

von Hösslin T, Imboden P, Lüthi A, Rozanski MJ, Schnider TW, Filipovic M.

Eur J Anaesthesiol. 2016 Oct;33(10):708-14. doi: 10.1097/EJA.0000000000000446.

PMID:
26954252
17.

Copeptin Levels in Patients With Acute Ischemic Stroke and Stroke Mimics.

Wendt M, Ebinger M, Kunz A, Rozanski M, Waldschmidt C, Weber JE, Winter B, Koch PM, Nolte CH, Hertel S, Ziera T, Audebert HJ; STEMO Consortium.

Stroke. 2015 Sep;46(9):2426-31. doi: 10.1161/STROKEAHA.115.009877. Epub 2015 Aug 6.

PMID:
26251255
18.

Natural course of total mismatch and predictors for tissue infarction.

Hotter B, Ostwaldt AC, Levichev-Connolly A, Rozanski M, Audebert HJ, Fiebach JB.

Neurology. 2015 Sep 1;85(9):770-5. doi: 10.1212/WNL.0000000000001889. Epub 2015 Jul 31.

PMID:
26231256
19.

Symptoms During or Shortly After Isolated Carpal Tunnel Release and Problems Within 24 hours After Surgery.

Rozanski M, Neuhaus V, Thornton E, Becker SJ, Rathmell JP, Ring D.

J Hand Microsurg. 2015 Jun;7(1):30-5. doi: 10.1007/s12593-014-0157-z. Epub 2014 Sep 4.

20.

Hyperintense acute reperfusion marker is associated with higher contrast agent dosage in acute ischaemic stroke.

Ostwaldt AC, Rozanski M, Schaefer T, Ebinger M, Jungehülsing GJ, Villringer K, Fiebach JB.

Eur Radiol. 2015 Nov;25(11):3161-6. doi: 10.1007/s00330-015-3749-5. Epub 2015 Apr 22.

PMID:
25899419
21.

Improved prehospital triage of patients with stroke in a specialized stroke ambulance: results of the pre-hospital acute neurological therapy and optimization of medical care in stroke study.

Wendt M, Ebinger M, Kunz A, Rozanski M, Waldschmidt C, Weber JE, Winter B, Koch PM, Freitag E, Reich J, Schremmer D, Audebert HJ; STEMO Consortium.

Stroke. 2015 Mar;46(3):740-5. doi: 10.1161/STROKEAHA.114.008159. Epub 2015 Jan 29.

PMID:
25634000
22.

An open-label comparison of local anesthesia with or without sedation for minor hand surgery.

Rozanski M, Neuhaus V, Reddy R, Jupiter JB, Rathmell JP, Ring DC.

Hand (N Y). 2014 Dec;9(4):399-405. doi: 10.1007/s11552-014-9670-6.

23.

Effects of golden hour thrombolysis: a Prehospital Acute Neurological Treatment and Optimization of Medical Care in Stroke (PHANTOM-S) substudy.

Ebinger M, Kunz A, Wendt M, Rozanski M, Winter B, Waldschmidt C, Weber J, Villringer K, Fiebach JB, Audebert HJ.

JAMA Neurol. 2015 Jan;72(1):25-30. doi: 10.1001/jamaneurol.2014.3188.

PMID:
25402214
24.

Number of cerebral microbleeds and risk of intracerebral hemorrhage after intravenous thrombolysis.

Dannenberg S, Scheitz JF, Rozanski M, Erdur H, Brunecker P, Werring DJ, Fiebach JB, Nolte CH.

Stroke. 2014 Oct;45(10):2900-5. doi: 10.1161/STROKEAHA.114.006448. Epub 2014 Aug 12.

PMID:
25116882
25.

Spectroscopic properties of transparent Er-doped oxyfluoride glass-ceramics with GdF₃.

Środa M, Szlósarczyk K, Różański M, Sitarz M, Jeleń P.

Spectrochim Acta A Mol Biomol Spectrosc. 2015 Jan 5;134:631-7. doi: 10.1016/j.saa.2014.06.066. Epub 2014 Jun 28.

PMID:
25049170
26.

Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial.

Ebinger M, Winter B, Wendt M, Weber JE, Waldschmidt C, Rozanski M, Kunz A, Koch P, Kellner PA, Gierhake D, Villringer K, Fiebach JB, Grittner U, Hartmann A, Mackert BM, Endres M, Audebert HJ; STEMO Consortium.

JAMA. 2014 Apr 23-30;311(16):1622-31. doi: 10.1001/jama.2014.2850.

PMID:
24756512
27.

Elevated levels of hemoglobin A1c are associated with cerebral white matter disease in patients with stroke.

Rozanski M, Richter TB, Grittner U, Endres M, Fiebach JB, Jungehulsing GJ.

Stroke. 2014 Apr;45(4):1007-11. doi: 10.1161/STROKEAHA.114.004740. Epub 2014 Feb 25.

PMID:
24569817
28.

Early time course of FLAIR signal intensity differs between acute ischemic stroke patients with and without hyperintense acute reperfusion marker.

Ostwaldt AC, Rozanski M, Schmidt WU, Nolte CH, Hotter B, Jungehuelsing GJ, Villringer K, Fiebach JB.

Cerebrovasc Dis. 2014;37(2):141-6. doi: 10.1159/000357422. Epub 2014 Jan 30.

PMID:
24481492
29.

Prehospital thrombolysis: a manual from Berlin.

Ebinger M, Lindenlaub S, Kunz A, Rozanski M, Waldschmidt C, Weber JE, Wendt M, Winter B, Kellner PA, Kaczmarek S, Endres M, Audebert HJ.

J Vis Exp. 2013 Nov 26;(81):e50534. doi: 10.3791/50534.

30.

Prehospital thrombolysis in acute stroke: results of the PHANTOM-S pilot study.

Weber JE, Ebinger M, Rozanski M, Waldschmidt C, Wendt M, Winter B, Kellner P, Baumann A, Fiebach JB, Villringer K, Kaczmarek S, Endres M, Audebert HJ; STEMO-Consortium.

Neurology. 2013 Jan 8;80(2):163-8. doi: 10.1212/WNL.0b013e31827b90e5. Epub 2012 Dec 5.

PMID:
23223534
31.

FLAIR vascular hyperintensities in acute ICA and MCA infarction: a marker for mismatch and stroke severity?.

Hohenhaus M, Schmidt WU, Brunecker P, Xu C, Hotter B, Rozanski M, Fiebach JB, Jungehülsing GJ.

Cerebrovasc Dis. 2012;34(1):63-9. doi: 10.1159/000339012. Epub 2012 Jun 28.

PMID:
22759720
32.

PHANTOM-S: the prehospital acute neurological therapy and optimization of medical care in stroke patients - study.

Ebinger M, Rozanski M, Waldschmidt C, Weber J, Wendt M, Winter B, Kellner P, Baumann AM, Malzahn U, Heuschmann PU, Fiebach JB, Endres M, Audebert HJ; STEMO-Consortium.

Int J Stroke. 2012 Jun;7(4):348-53. doi: 10.1111/j.1747-4949.2011.00756.x. Epub 2012 Feb 2.

PMID:
22300008
33.

Development and validation of a dispatcher identification algorithm for stroke emergencies.

Krebes S, Ebinger M, Baumann AM, Kellner PA, Rozanski M, Doepp F, Sobesky J, Gensecke T, Leidel BA, Malzahn U, Wellwood I, Heuschmann PU, Audebert HJ.

Stroke. 2012 Mar;43(3):776-81. doi: 10.1161/STROKEAHA.111.634980. Epub 2012 Jan 5.

PMID:
22223240
34.

Successful laparoscopic treatment of a hepatic abscess due to a chicken bone.

Rozanski M, Neuhaus V, Fahrner R, Schoeb O.

Am Surg. 2010 Sep;76(9):1027-8. No abstract available.

PMID:
20836360
35.

Hyperintense acute reperfusion marker on FLAIR is not associated with early haemorrhagic transformation in the elderly.

Rozanski M, Ebinger M, Schmidt WU, Hotter B, Pittl S, Heuschmann PU, Jungehuelsing JG, Fiebach JB.

Eur Radiol. 2010 Dec;20(12):2990-6. doi: 10.1007/s00330-010-1881-9. Epub 2010 Jul 21.

PMID:
20652257
36.

Clinical and radiological courses do not differ between fluid-attenuated inversion recovery-positive and negative patients with stroke after thrombolysis.

Ebinger M, Ostwaldt AC, Galinovic I, Rozanski M, Brunecker P, Nolte CH, Endres M, Fiebach JB.

Stroke. 2010 Aug;41(8):1823-5. doi: 10.1161/STROKEAHA.110.583971. Epub 2010 Jul 1.

PMID:
20595662
37.

Fluid-attenuated inversion recovery evolution within 12 hours from stroke onset: a reliable tissue clock?

Ebinger M, Galinovic I, Rozanski M, Brunecker P, Endres M, Fiebach JB.

Stroke. 2010 Feb;41(2):250-5. doi: 10.1161/STROKEAHA.109.568410. Epub 2009 Dec 24.

PMID:
20035068
38.

Prospective study on the mismatch concept in acute stroke patients within the first 24 h after symptom onset - 1000Plus study.

Hotter B, Pittl S, Ebinger M, Oepen G, Jegzentis K, Kudo K, Rozanski M, Schmidt WU, Brunecker P, Xu C, Martus P, Endres M, Jungehülsing GJ, Villringer A, Fiebach JB.

BMC Neurol. 2009 Dec 8;9:60. doi: 10.1186/1471-2377-9-60.

39.

Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial.

Pönisch W, Rozanski M, Goldschmidt H, Hoffmann FA, Boldt T, Schwarzer A, Ritter U, Rohrberg R, Schwalbe E, Uhlig J, Zehrfeld T, Schirmer V, Haas A, Kreibich U, Niederwieser D; East German Study Group of Haematology and Oncology (OSHO).

Br J Haematol. 2008 Oct;143(2):191-200. doi: 10.1111/j.1365-2141.2008.07076.x. Epub 2008 Aug 24.

PMID:
18752593
40.

Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice.

Leinhase I, Rozanski M, Harhausen D, Thurman JM, Schmidt OI, Hossini AM, Taha ME, Rittirsch D, Ward PA, Holers VM, Ertel W, Stahel PF.

J Neuroinflammation. 2007 May 2;4:13.

41.

Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury.

Leinhase I, Schmidt OI, Thurman JM, Hossini AM, Rozanski M, Taha ME, Scheffler A, John T, Smith WR, Holers VM, Stahel PF.

Exp Neurol. 2006 Jun;199(2):454-64. Epub 2006 Mar 20.

PMID:
16545803

Supplemental Content

Loading ...
Support Center